| Name |
Final products |
CAS |
Quality standard |
Chemical structure |
| Sitagliptin phosphate monohydrate API |
Sitagliptin phosphate monohydrate and its intermediates |
654671-77-9 |
Assay >99.5%Optical purity：>99.0% |
 |
| Rivaroxaban |
Rivaroxaban and its intermediates |
366789-02-8 |
Purity >99.0% |
 |
| 2-(3-nitrobenzylidene)acetoacetate;Isopropyl |
Azelnidipine and its intermediates |
39562-25-9 |
Customer’s requirement |
 |
| 1-Diphenylmethyl-3-hydroxyazetidine |
Azelnidipine and its intermediates |
1862-17-5 |
Customer’s requirement |
 |
| 3-Amino-3-iminopropanoic acid 1-(diphenylmethyl)-3-azetidinyl ester acetate |
Azelnidipine and its intermediates |
170749-59-4 |
Customer’s requirement |
 |
| Pitavastatin Calcium |
Pitavastatin Calcium and its intermediates |
147526-32-7 |
≥98.5%;enantiomer≤0.5% |
 |
| (3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid tert-butyl ester |
Pitavastatin Calcium and its intermediates |
586966-54-3 |
≥98% |
 |
| (3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]- 3,5-dihydrosy-6-heptane acid |
Pitavastatin Calcium and its intermediates |
147511-70-4 |
≥98% |
 |
| Febuxostat |
Febuxostat |
144060-53-7 |
Single impurity <0.1% |
 |
| Celecoxib |
|
169590-42-5 |
single impurity <0.1% |
 |